We heard from the CEO of Celgene, Sol Barer, during an interview with Wishart at a $350 a head dinner, which all on its own somewhat negated his argument that profit isn’t at the heart of what Revlimid costs. … Business is business, and whatever it is you’re selling, you want to make the most money possible out of it.

Read more from the original source: 
Last Night's TV – The Price of Life @ Unreality Primetime

This entry was posted on Thursday, June 18th, 2009 at 2:40 am and is filed under Interviewing Unwrapped. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.